Jochen H. Lorch, MD, MS
Advertisement
Articles by Jochen H. Lorch, MD, MS
A key opinion leader reviews the case of a 71-year-old woman with NTRK gene fusion thyroid cancer and considers novel therapies available for the management of her disease.
Advertisement
Latest Updated Articles
Preferred Testing Methods and Treatment OptionsPublished: September 21st 2020 | Updated:
- LOXO-101 Trial Regimen Overview
Published: September 21st 2020 | Updated:
- A 71-Year-Old Woman With NTRK Gene Fusion Thyroid Cancer
Published: September 21st 2020 | Updated:
- NTRK Gene Fusion Thyroid Cancer: Incidence and Prognosis
Published: September 21st 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD
5
